Allspring Global Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.4M Buy
1,019,768
+399,171
+64% +$10.4M 0.04% 515
2026
Q1
$17.7M Sell
620,597
-241,954
-28% -$6.44M 0.03% 559
2025
Q4
$21.7M Buy
862,551
+14,715
+2% +$371K 0.04% 511
2025
Q3
$23.1M Buy
847,836
+6,455
+0.8% +$159K 0.04% 504
2025
Q2
$21.1M Sell
841,381
-341,449
-29% -$7.96M 0.04% 505
2025
Q1
$29M Buy
1,182,830
+330,019
+39% +$8.64M 0.05% 426
2024
Q4
$22.7M Sell
852,811
-23,580
-3% -$640K 0.04% 500
2024
Q3
$25.4M Sell
876,391
-142,353
-14% -$4.15M 0.04% 499
2024
Q2
$28.5M Sell
1,018,744
-577,649
-36% -$15.9M 0.05% 459
2024
Q1
$44.3M Sell
1,596,393
-838,515
-34% -$23.3M 0.07% 360
2023
Q4
$70.1M Buy
2,434,908
+333,716
+16% +$10.1M 0.12% 227
2023
Q3
$69.7M Buy
2,101,192
+475,157
+29% +$16.8M 0.12% 204
2023
Q2
$59.6M Sell
1,626,035
-93,443
-5% -$3.64M 0.1% 268
2023
Q1
$70.2M Sell
1,719,478
-74,769
-4% -$3.23M 0.12% 230
2022
Q4
$91.9M Sell
1,794,247
-1,558,715
-46% -$74.7M 0.16% 161
2022
Q3
$147M Sell
3,352,962
-216,565
-6% -$10.5M 0.26% 78
2022
Q2
$187M Sell
3,569,527
-693,155
-16% -$35.3M 0.31% 64
2022
Q1
$221M Sell
4,262,682
-177,763
-4% -$9.22M 0.28% 77
2021
Q4
$262M Buy
+4,440,445
New +$220M 0.29% 65

Other funds holding PFE

Allspring Global Investments's PFE Position: Q2 2026 in Review

Allspring Global Investments increased its Pfizer (PFE) stake by 64% in Q2 2026, buying an estimated $10.4M and bringing the position to 1,019,768 shares worth $24.4M. The position accounts for 0.04% of the portfolio, ranked #515.

Allspring Global Investments first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $262M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Allspring Global Investments held 1,019,768 shares of Pfizer worth $24.4M as of Q2 2026.
  • Allspring Global Investments bought 399,171 Pfizer shares in Q2 2026, an estimated $10.4M.
  • Pfizer made up 0.04% of Allspring Global Investments's portfolio in Q2 2026, its #515 holding.
  • Allspring Global Investments first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Allspring Global Investments's Pfizer position peaked at $262M in Q4 2021.
  • 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.